Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present GenMark Diagnostics, Inc. (NASDAQ: GNMK).

Full DD Report for GNMK

You must become a subscriber to view this report.


Recent News from (NASDAQ: GNMK)

GenMark Diagnostics to Present at Upcoming Investor Conferences
CARLSBAD, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the company plans to participate in two upcoming investor conferences. GenMark’s management...
Source: GlobeNewswire
Date: November, 07 2018 16:05
Analysis: Positioning to Benefit within Hess Midstream Partners LP, Quanta Services, ServiceSource International, Meritor, Donegal Group, and GenMark Diagnostics - Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Nov. 06, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Hess Midstream Partners LP (NYSE:HESM), Quanta Services, Inc. (NYSE:PWR),...
Source: GlobeNewswire
Date: November, 06 2018 07:50
GenMark Diagnostics, Inc. (GNMK) CEO Hany Massarany on Q3 2018 Results - Earnings Call Transcript
GenMark Diagnostics, Inc. (GNMK) Q3 2018 Earnings Conference Call October 29, 2018 04:30 PM ET Executives Johnny Ek - Corporate Controller Hany Massarany - President & CEO Scott Mendel - CFO Analysts Mark Massaro - Canaccord Doug Schenkel - Cowen Tycho Peterson - ...
Source: SeekingAlpha
Date: October, 29 2018 21:01
GenMark Diagnostics EPS in-line, beats on revenue
GenMark Diagnostics (NASDAQ: GNMK ): Q3 GAAP EPS of -$0.20 in-line. More news on: GenMark Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: October, 29 2018 16:15
GenMark Diagnostics Reports Third Quarter 2018 Results
CARLSBAD, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the third quarter ended September 30, 2018. Highlights Recognized reve...
Source: GlobeNewswire
Date: October, 29 2018 16:05
GenMark Diagnostics Schedules Third Quarter Financial Results Conference Call for October 29, 2018
CARLSBAD, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close on Monday, October 29, 2018. Management will hold a conference call to review the Company's financ...
Source: GlobeNewswire
Date: October, 15 2018 16:05
Analysis: Positioning to Benefit within PTC, H&R Block, GenMark Diagnostics, American International Group, Newmont Mining, and Stryker - Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of PTC Inc. (NASDAQ:PTC), H&R Block, Inc. (NYSE:HRB), GenMark Diagnos...
Source: GlobeNewswire
Date: October, 15 2018 09:25
GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram-Negative and ePlex Blood Culture Identification Fungal Pathogen Panels
CARLSBAD, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the submission of two additional ePlex Blood Culture Identification Panels – the Gram-Negative (B...
Source: GlobeNewswire
Date: October, 02 2018 16:14
Recent Analysis Shows SUPERVALU INC, GenMark Diagnostics, E.W. Scripps, Cooper Tire & Rubber, Nexstar Broadcasting Group, and Cloud Peak Energy Market Influences - Renewed Outlook, Key Drivers of Growth
NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of SUPERVALU INC. (NYSE:SVU), GenMark Diagnostics, Inc. (NASDAQ:GNMK), E.W. ...
Source: GlobeNewswire
Date: August, 13 2018 08:30
GenMark Diagnostics, Inc. (GNMK) CEO Hany Massarany on Q2 2018 Results - Earnings Call Transcript
GenMark Diagnostics, Inc. (GNMK) Q2 2018 Results Earnings Conference Call July 30, 2018, 04:30 PM ET Executives Johnny Ek - Corporate Controller Hany Massarany - CEO, President Scott Mendel - CFO Analysts Doug Schenkel - Cowen Brian Weinstein - William Blair Mark Massar...
Source: SeekingAlpha
Date: July, 30 2018 23:03

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-088.138.148.36258.08193,006
2018-05-176.926.897.026.85175,717
2018-02-264.174.534.664.17712,807
2018-02-234.294.254.304.12190,928
2018-02-224.434.254.514.115333,136

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1333,976126,58426.8407Cover
2018-12-129,41231,64529.7425Cover
2018-12-1116,84762,72726.8577Cover
2018-12-1081,826169,10848.3868Short
2018-12-0748,141135,46235.5384Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on GNMK.


About GenMark Diagnostics, Inc. (NASDAQ: GNMK)

Logo for GenMark Diagnostics, Inc. (NASDAQ: GNMK)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: GNMK)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 01 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 01 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 13 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 13 2018
      Filing Type: CT ORDERFiling Source: edgar
      Filing Date: March, 27 2018
      Filing by person(s) reporting owned shares of common stock in a public company >5%
      Filing Type: SC 13DFiling Source: edgar
      Filing Date: March, 27 2018
      Securities offered to employees under employee benefit plans
      Filing Type: S-8Filing Source: edgar
      Filing Date: March, 01 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 01 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: February, 27 2018
      Annual report with a comprehensive overview of the company
      Filing Type: 10-KFiling Source: edgar
      Filing Date: February, 27 2018

       

       


      Daily Technical Chart for (NASDAQ: GNMK)

      Daily Technical Chart for (NASDAQ: GNMK)


      Stay tuned for daily updates and more on (NASDAQ: GNMK)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: GNMK)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in GNMK is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of GNMK and does not buy, sell, or trade any shares of GNMK. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/